share_log

We Ran A Stock Scan For Earnings Growth And Shenzhen RongDa Photosensitive Science & Technology (SZSE:300576) Passed With Ease

We Ran A Stock Scan For Earnings Growth And Shenzhen RongDa Photosensitive Science & Technology (SZSE:300576) Passed With Ease

我們對股票進行了盈利增長掃描,深圳榮達光敏科技(SZSE: 300576)輕鬆通過
Simply Wall St ·  03/11 02:57

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. But as Peter Lynch said in One Up On Wall Street, 'Long shots almost never pay off.' Loss-making companies are always racing against time to reach financial sustainability, so investors in these companies may be taking on more risk than they should.

投資者通常以發現 “下一件大事” 的想法爲指導,即使這意味着在沒有任何收入的情況下購買 “故事股票”,更不用說獲利了。但是正如彼得·林奇所說 One Up On Wall 街,“遠射幾乎永遠不會得到回報。”虧損的公司總是與時間賽跑以實現財務可持續性,因此這些公司的投資者承擔的風險可能超出了應有的範圍。

So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like Shenzhen RongDa Photosensitive Science & Technology (SZSE:300576). While this doesn't necessarily speak to whether it's undervalued, the profitability of the business is enough to warrant some appreciation - especially if its growing.

因此,如果這種高風險和高回報的想法不適合,你可能會對盈利、成長中的公司更感興趣,例如深圳容大光敏科技(SZSE: 300576)。儘管這並不一定說明其估值是否被低估,但該業務的盈利能力足以保證一定的升值——尤其是在其增長的情況下。

How Quickly Is Shenzhen RongDa Photosensitive Science & Technology Increasing Earnings Per Share?

深圳容大光敏科技每股收益的增長速度有多快?

Generally, companies experiencing growth in earnings per share (EPS) should see similar trends in share price. That makes EPS growth an attractive quality for any company. Shareholders will be happy to know that Shenzhen RongDa Photosensitive Science & Technology's EPS has grown 20% each year, compound, over three years. As a result, we can understand why the stock trades on a high multiple of trailing twelve month earnings.

通常,每股收益(EPS)增長的公司的股價應該會出現類似的趨勢。這使得每股收益的增長對任何公司來說都是一種有吸引力的品質。股東們會很高興得知,深圳容大光敏科技的每股收益在三年內每年複合增長20%。因此,我們可以理解爲什麼股票的交易價格是過去十二個月收益的高倍數。

Careful consideration of revenue growth and earnings before interest and taxation (EBIT) margins can help inform a view on the sustainability of the recent profit growth. Shenzhen RongDa Photosensitive Science & Technology shareholders can take confidence from the fact that EBIT margins are up from 4.7% to 12%, and revenue is growing. Both of which are great metrics to check off for potential growth.

仔細考慮收入增長和息稅前收益(EBIT)利潤率有助於爲近期利潤增長的可持續性提供信息。息稅前利潤率從4.7%上升到12%,收入不斷增長,深圳榮達光敏科技股東可以從中獲得信心。這兩個指標都是衡量潛在增長的好指標。

You can take a look at the company's revenue and earnings growth trend, in the chart below. To see the actual numbers, click on the chart.

您可以在下表中查看該公司的收入和收益增長趨勢。要查看實際數字,請單擊圖表。

earnings-and-revenue-history
SZSE:300576 Earnings and Revenue History March 11th 2024
SZSE: 300576 2024 年 3 月 11 日的收益和收入歷史記錄

While it's always good to see growing profits, you should always remember that a weak balance sheet could come back to bite. So check Shenzhen RongDa Photosensitive Science & Technology's balance sheet strength, before getting too excited.

雖然看到利潤增長總是件好事,但你應該永遠記住,疲軟的資產負債表可能會捲土重來。因此,在興奮之前,請先查看深圳榮達感光科技的資產負債表實力。

Are Shenzhen RongDa Photosensitive Science & Technology Insiders Aligned With All Shareholders?

深圳榮達感光科技業內人士是否與所有股東保持一致?

Many consider high insider ownership to be a strong sign of alignment between the leaders of a company and the ordinary shareholders. So we're pleased to report that Shenzhen RongDa Photosensitive Science & Technology insiders own a meaningful share of the business. In fact, they own 53% of the company, so they will share in the same delights and challenges experienced by the ordinary shareholders. This makes it apparent they will be incentivised to plan for the long term - a positive for shareholders with a sit and hold strategy. at the current share price. That level of investment from insiders is nothing to sneeze at.

許多人認爲,高內部所有權是公司領導人和普通股東之間達成一致的有力標誌。因此,我們很高興地向大家報告,深圳容大光敏科技內部人士擁有該業務的重要份額。實際上,他們擁有公司53%的股份,因此他們將分享普通股東所經歷的同樣的樂趣和挑戰。這清楚地表明,按目前的股價計算,他們將受到激勵進行長期規劃——這對持倉策略的股東來說是積極的。內部人士的這種投資水平沒什麼好打噴嚏的。

It's good to see that insiders are invested in the company, but are remuneration levels reasonable? Well, based on the CEO pay, you'd argue that they are indeed. For companies with market capitalisations between CN¥7.2b and CN¥23b, like Shenzhen RongDa Photosensitive Science & Technology, the median CEO pay is around CN¥1.2m.

很高興看到內部人士投資於公司,但是薪酬水平是否合理?好吧,根據首席執行官的薪酬,你會認爲確實如此。對於市值介於72億元至23億元人民幣之間的公司,例如深圳榮大光敏科技公司,首席執行官薪酬中位數約爲120萬元人民幣。

The Shenzhen RongDa Photosensitive Science & Technology CEO received CN¥876k in compensation for the year ending December 2022. That is actually below the median for CEO's of similarly sized companies. CEO remuneration levels are not the most important metric for investors, but when the pay is modest, that does support enhanced alignment between the CEO and the ordinary shareholders. It can also be a sign of good governance, more generally.

深圳榮達光敏科技首席執行官在截至2022年12月的年度中獲得了87.6萬元人民幣的薪酬。這實際上低於類似規模公司首席執行官的中位數。首席執行官薪酬水平並不是投資者最重要的指標,但是當薪酬適度時,這確實支持加強首席執行官與普通股東之間的協調。更籠統地說,它也可以是善治的標誌。

Does Shenzhen RongDa Photosensitive Science & Technology Deserve A Spot On Your Watchlist?

深圳容大光敏科技值得在您的關注清單上佔有一席之地嗎?

If you believe that share price follows earnings per share you should definitely be delving further into Shenzhen RongDa Photosensitive Science & Technology's strong EPS growth. If you need more convincing beyond that EPS growth rate, don't forget about the reasonable remuneration and the high insider ownership. This may only be a fast rundown, but the key takeaway is that Shenzhen RongDa Photosensitive Science & Technology is worth keeping an eye on. Still, you should learn about the 3 warning signs we've spotted with Shenzhen RongDa Photosensitive Science & Technology (including 1 which is significant).

如果你認爲股價跟隨每股收益,那麼你肯定應該進一步研究深圳榮大光敏科技強勁的每股收益增長。如果您除了每股收益增長率之外還需要更多說服力,請不要忘記合理的薪酬和較高的內部所有權。這可能只是一個簡短的概述,但關鍵要點是深圳容大光敏科技值得關注。不過,你應該了解我們在深圳容大光敏科技發現的3個警告信號(包括一個重要的警示信號)。

There's always the possibility of doing well buying stocks that are not growing earnings and do not have insiders buying shares. But for those who consider these important metrics, we encourage you to check out companies that do have those features. You can access a tailored list of Chinese companies which have demonstrated growth backed by recent insider purchases.

買入這樣的股票總是有可能表現不錯 不是 不斷增長的收入和 不要 讓內部人士購買股票。但是,對於那些考慮這些重要指標的人,我們鼓勵您查看具有這些功能的公司。您可以訪問量身定製的中國公司名單,這些公司在最近的內幕收購的支持下實現了增長。

Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction.

請注意,本文中討論的內幕交易是指相關司法管轄區內應報告的交易。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論